Holistic Extractables and Leachables Program: Evaluations of Prefilled Syringe Systems for Biotechnology Products. 2020

Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
Attribute Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320; mronk@amgen.com snashed@amgen.com.

Prefilled syringes (PFS) are a container and delivery device of choice for storing and administering therapeutic protein products to patients. Addressing concerns and regulatory expectations related to the risk to biologic drug product quality and patient safety from PFS requires implementation of an extractable and leachable program based on understanding of materials, risk assessment, review of existing literature, and testing supported by a sound scientific foundation. Extractables and leachables data generated as part of a thorough and holistic program are presented for five PFS systems, including glass and plastic syringes filled with 12 biologic drug products encompassing the implementation of traditional and single-use biotechnology manufacturing processes. The comprehensive extractables and leachables data presented demonstrate and substantiate a holistic extractable and leachable program designed to ensure product quality and patient safety.

UI MeSH Term Description Entries
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations
D004349 Drug Packaging Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available. Drug Containers and Closures,Packaging, Drug,Drug Containers,Container, Drug,Containers, Drug,Drug Container,Drug Packagings,Packagings, Drug
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D004356 Drug Storage The process of keeping pharmaceutical products in an appropriate location. Drug Storages,Storage, Drug,Storages, Drug
D006694 Holistic Health Health as viewed from the perspective that humans function as complete, integrated units rather than as aggregates of separate parts. Holistic Medicine,Holistic Therapies,Medicine, Holistic,Whole Person Health,Wholistic Health,Medicine, Wholistic,Wholistic Health Care,Wholistic Medicine,Wholistic Therapies,Care, Wholistic Health,Health Care, Wholistic,Health, Holistic,Health, Whole Person,Health, Wholistic,Holistic Therapy,Person Health, Whole,Therapies, Holistic,Therapies, Wholistic,Therapy, Holistic,Therapy, Wholistic,Wholistic Therapy
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D001709 Biotechnology Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction. Biotechnologies

Related Publications

Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
January 2015, PDA journal of pharmaceutical science and technology,
Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
October 2014, Expert opinion on drug delivery,
Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
January 2022, PDA journal of pharmaceutical science and technology,
Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
July 2022, Environmental science & technology,
Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
January 2010, PDA journal of pharmaceutical science and technology,
Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
January 2020, PDA journal of pharmaceutical science and technology,
Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
January 2021, PDA journal of pharmaceutical science and technology,
Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
February 2022, Critical reviews in toxicology,
Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
December 2020, Regulatory toxicology and pharmacology : RTP,
Michael Ronk, and Jian Liu, and Alejandra Gallegos, and Yanxin Luo, and Kiyoshi Fujimori, and Kim Li, and Hans Lee, and Yasser Nashed-Samuel
January 2005, PDA journal of pharmaceutical science and technology,
Copied contents to your clipboard!